Cargando…
Prediction of Glioblastoma Multiform Response to Bevacizumab Treatment Using Multi-Parametric MRI
Glioblastoma multiform (GBM) is a highly malignant brain tumor. Bevacizumab is a recent therapy for stopping tumor growth and even shrinking tumor through inhibition of vascular development (angiogenesis). This paper presents a non-invasive approach based on image analysis of multi-parametric magnet...
Autores principales: | Najafi, Mohammad, Soltanian-Zadeh, Hamid, Jafari-Khouzani, Kourosh, Scarpace, Lisa, Mikkelsen, Tom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256204/ https://www.ncbi.nlm.nih.gov/pubmed/22253835 http://dx.doi.org/10.1371/journal.pone.0029945 |
Ejemplares similares
-
Predicting Final Extent of Ischemic Infarction Using Artificial Neural Network Analysis of Multi-Parametric MRI in Patients with Stroke
por: Bagher-Ebadian, Hassan, et al.
Publicado: (2011) -
Classifying Glioblastoma Multiforme Follow-Up Progressive vs. Responsive Forms Using Multi-Parametric MRI Features
por: Ion-Mărgineanu, Adrian, et al.
Publicado: (2017) -
Update and developments in the treatment of glioblastoma multiforme – focus on bevacizumab
por: Wagle, Naveed, et al.
Publicado: (2010) -
Differentiation of Glioma and Radiation Injury in Rats Using In Vitro Produce Magnetically Labeled Cytotoxic T-Cells and MRI
por: Arbab, Ali S., et al.
Publicado: (2010) -
Parametric Response Maps of Perfusion MRI May Identify Recurrent Glioblastomas Responsive to Bevacizumab and Irinotecan
por: Aquino, Domenico, et al.
Publicado: (2014)